Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyman Regulatory News (TYMN)

  • This share is currently suspended. It was suspended at a price of 398.00
  • There is currently no data for TYMN

Holding(s) in Company

26 Jul 2024 12:11

RNS Number : 0581Y
Tyman PLC
26 July 2024
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00B29H4253

Issuer Name

TYMAN PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

JPMorgan Chase & Co.

City of registered office (if applicable)

 

Country of registered office (if applicable)

US

4. Details of the shareholder

Name

City of registered office

Country of registered office

J.P. Morgan Securities plc

5. Date on which the threshold was crossed or reached

24-Jul-2024

6. Date on which Issuer notified

26-Jul-2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

5.274560

0.008052

5.282612

10370981

Position of previous notification (if applicable)

6.402458

0.009106

6.411564

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00B29H4253

10355155

5.274560

Sub Total 8.A

10355155

5.274560%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Cash-settled Equity Swap

18/09/2024

18/09/2024

Cash

1685

0.000858

Cash-settled Equity Swap

05/06/2025

05/06/2025

Cash

1976

0.001006

Cash-settled Equity Swap

27/06/2025

27/06/2025

Cash

2622

0.001328

Cash-settled Equity Swap

02/07/2025

02/07/2025

Cash

1211

0.000616

Cash-settled Equity Swap

29/08/2025

29/08/2025

Cash

8332

0.004244

Sub Total 8.B2

15826

0.008052%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

JPMorgan Chase & Co.

J.P. Morgan Securities plc

5.273683

5.281735%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Chain of controlled undertakings:JPMorgan Chase & Co.JPMorgan Chase Bank, National Association (100%)J.P. Morgan International Finance Limited (100%)J.P. Morgan Capital Holdings Limited (100%)J.P. Morgan Securities plc (100%)JPMorgan Chase & Co.JPMorgan Chase Holdings LLC (100%)J.P. Morgan Broker-Dealer Holdings Inc. (100%)J.P. Morgan Securities LLC (100%)

12. Date of Completion

26-Jul-2024

13. Place Of Completion

London, United Kingdom

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLRFMBTMTMTBPI
Date   Source Headline
5th Oct 20225:01 pmRNSHolding(s) in Company
5th Oct 20225:00 pmRNSHolding(s) in Company
5th Oct 20224:04 pmRNSHolding(s) in Company
19th Aug 20223:33 pmRNSHolding(s) in Company
1st Aug 20223:34 pmRNSHolding(s) in Company
26th Jul 20227:00 amRNSHalf-year Report
17th Jun 20224:23 pmRNSHolding(s) in Company
6th Jun 20228:08 amRNSDirector/PDMR Shareholding
24th May 20229:57 amRNSDirector/PDMR Shareholding
19th May 20224:41 pmRNSDirector/PDMR Shareholding
19th May 20224:40 pmRNSResult of AGM
19th May 20227:00 amRNSAGM Trading Update
26th Apr 20225:14 pmRNSHolding(s) in Company
25th Apr 20223:36 pmRNSHolding(s) in Company
20th Apr 20223:59 pmRNSDirector/PDMR Shareholding
11th Apr 202211:30 amRNSDirector/PDMR Shareholding
1st Apr 20224:00 pmRNSHolding(s) in Company
1st Apr 20227:00 amRNSNotice of AGM
31st Mar 20229:56 amRNSHolding(s) in Company
31st Mar 20229:51 amRNSHolding(s) in Company
29th Mar 20223:07 pmRNSHolding(s) in Company
29th Mar 202212:00 pmRNSEBT Purchase
29th Mar 202210:54 amRNSHolding(s) in Company
15th Mar 20227:00 amRNSRefinancing of US Private Placement Notes
10th Mar 20223:12 pmRNSDirector/PDMR Shareholding
10th Mar 20222:43 pmRNSHolding(s) in Company
8th Mar 202212:09 pmRNSHolding(s) in Company
3rd Mar 20223:21 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSFinal Results
22nd Feb 20224:10 pmRNSNotice of Results
25th Jan 202210:05 amRNSDirector Declaration
16th Dec 20217:00 amRNSNew Non-Executive Director
25th Nov 202112:57 pmRNSTotal Voting Rights
17th Nov 20217:00 amRNSTrading Update
28th Oct 20219:43 amRNSHolding(s) in Company
14th Sep 20217:49 amRNSHolding(s) in Company
13th Aug 202110:21 amRNSChange of Auditor
30th Jul 20213:28 pmRNSHolding(s) in Company
27th Jul 20217:00 amRNSHalf-year Report
2nd Jun 202112:06 pmRNSHolding(s) in Company
2nd Jun 202112:00 pmRNSHolding(s) in Company
1st Jun 20214:12 pmRNSHolding(s) in Company
1st Jun 20213:53 pmRNSHolding(s) in Company
25th May 20215:30 pmRNSRSA Insurance Group
24th May 20213:22 pmRNSDirector/PDMR Shareholding
20th May 20214:39 pmRNSResult of AGM
20th May 20217:00 amRNSCapital Markets Event
13th May 20214:45 pmRNSHolding(s) in Company
11th May 20214:38 pmRNSHolding(s) in Company
10th May 20214:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.